Corneal Staining and Physiological Compromise After Eight Hours of Soft Contact Lens Wear

NCT ID: NCT01015768

Last Updated: 2020-09-18

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-10-31

Study Completion Date

2010-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess corneal staining and to measure the relative corneal epithelial "barrier" function (the degree to which the cornea can prevent penetration of colored sodium fluorescein dye into the eye) after 8 hours of wear with a known soft contact lens and multipurpose lens care solution combination.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This investigation will evaluate corneal staining and epithelial barrier function after eight hours of contact lens wear, which is past the peak staining time and more typical of daily lens wear time. A silicone hydrogel lens and multipurpose solution combination shown to induce significant corneal staining ( e.g. equivalent Grade 3 out of Grade 4 scale) will be used to evaluate potential corneal compromise. The study will be a prospective, single-center, double-masked, contralateral, daily wear investigation in adapted soft contact lens wearers. After a three day washout period (without lens wear, lenses will then be worn on one day for eight hours. Corneal staining and barrier function will be determined for a regimen and a saline control situation for each subject. Staining will be graded using the Efron Grading Scale, and permeability data will be estimated as the fluorescein penetration rate, Pdc in nm/sec for the test and control condition.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Contact Lens-induced Corneal Fluorescein Staining

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Test eye

Uses ReNu Multiplus as multipurpose soaking solution

Group Type EXPERIMENTAL

ReNu Multiplus multipurpose disinfecting solution

Intervention Type DEVICE

A new lens (PureVision) soaked 6 hours to overnight in ReNu Multiplus

Control

A new lens (PureVision) is soaked for 2 hours in non-preserved saline

Group Type ACTIVE_COMPARATOR

Control

Intervention Type DEVICE

A new lens (PureVision) is soaked for two hours in non-preserved saline

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ReNu Multiplus multipurpose disinfecting solution

A new lens (PureVision) soaked 6 hours to overnight in ReNu Multiplus

Intervention Type DEVICE

Control

A new lens (PureVision) is soaked for two hours in non-preserved saline

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least 18 years of age.
* Understand your rights as a research subject and give written informed consent by signing the Informed Consent Form, Subject Bill of Rights, and Patient Authorization for Use and Release of Health and Research Study Information (HIPAA form).
* Be likely to finish the entire study, understand the study instructions, and be willing to follow the instructions.
* Contact lens prescription between +4.00 D to -9.00 D (spherical equivalent).
* Best correctable visual acuity of at least 20/40 in each eye.
* Willing to de-adapt (do not wear) from habitual contact lenses for a period of at least two days prior to eligibility visit and at least two days prior to the testing day.
* Possess a functional spectacle (eyeglass) prescription to allow adequate vision during the de-adaptation and barrier function determination periods.
* No known allergies, which may interfere with contact lens wear.
* No known systemic (pertaining to general health) disease, or need for medication that may interfere with contact lens wear (i.e. antihistamines, beta-blockers, steroids).

Exclusion Criteria

* Less than one month successful, full time (defined as at least 8 hours per day, and more than 5 days per week) soft lens wear.
* Clinically significant corneal swelling (greater than grade 3 or 4 on a 0-4 scale), corneal blood vessel growth (vascularization), corneal staining, bulbar redness, tarsal redness, or any other abnormality of the cornea that may cause unsafe contact lens wear.
* Any active ocular infection.
* Prior corneal refractive surgery (i.e., LASIK, PRK, etc).
* Have used medications within 24 hours of study entry or have an ongoing need to use ocular medication.
* Are taking part in any other study or have taken part in a study within the last 14 days
* Have a medical condition that your study eye doctor thinks may make it not appropriate for you to participate in this study.
* Are pregnant, or anticipate becoming pregnant during the course of this study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Southern California College of Optometry at Marshall B. Ketchum University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jerry R. Paugh, OD, PhD

Professor, Associate Dean or Research

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jerry R Paugh, OD, PhD

Role: STUDY_DIRECTOR

Southern California College of Optometry at Marshall B. Ketchum University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Southern California Colege of Optometry

Fullerton, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

08-10

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.